Deckers Brands vs AbbVie

About

Deckers Brands is a Goleta, California-based footwear and apparel company — publicly traded on the New York Stock Exchange (NYSE: DECK) as an S&P 500 Consumer Discretionary component — designing, marketing, and distributing footwear through four brands: HOKA (performance athletic running and trail shoes), UGG (sheepskin boots, slippers, and casual footwear), Teva (sport sandals), and Koolaburra (accessible sheepskin-style footwear) through approximately 4,300 employees globally. In fiscal year 2025 (ending March 2025), Deckers reported revenues of approximately $4.9 billion with HOKA generating over $2.2 billion (+16% growth) representing the most successful performance footwear brand launch in recent industry history — and UGG generating approximately $2.3 billion in its strongest year yet driven by the sheepskin boot cultural resurgence among Gen Z consumers embracing comfort-forward casual fashion. CEO Dave Powers has executed a brand portfolio strategy that counterintuitively benefits from multi-brand diversity: when outdoor athletic trends favor performance running (HOKA gains), casual comfort trends favor UGG, with the two largest brands often running on different consumer cycle timing. The direct-to-consumer expansion (DTC revenue growing to 45%+ of total sales) captures higher margins than wholesale channel sales — an UGG boot sold through deckers.com or an owned retail store generates 3-4x the gross margin dollar versus the same boot sold through Nordstrom or Dick's Sporting Goods, funding brand investment and driving customer lifetime value through owned digital relationships.